Graham Capital Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Sell |
19,372
-5,582
| -22% | -$61.6K | ﹤0.01% | 1068 |
|
|
2025
Q1 | $223K | Sell |
24,954
-11,410
| -31% | -$102K | ﹤0.01% | 1070 |
|
|
2024
Q4 | $342K | Buy |
36,364
+5,608
| +18% | +$52.8K | 0.01% | 850 |
|
|
2024
Q3 | $248K | Buy |
30,756
+2,197
| +8% | +$17.7K | ﹤0.01% | 820 |
|
|
2024
Q2 | $242K | Buy |
28,559
+12,206
| +75% | +$104K | 0.01% | 769 |
|
|
2024
Q1 | $147K | Buy |
+16,353
| New | +$147K | ﹤0.01% | 907 |
|
|
2023
Q3 | – | Sell |
-14,662
| Closed | -$152K | – | 1274 |
|
|
2023
Q2 | $152K | Sell |
14,662
-3,268
| -18% | -$33.8K | ﹤0.01% | 842 |
|
|
2023
Q1 | $195K | Buy |
+17,930
| New | +$195K | 0.01% | 958 |
|